Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trial

Patients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than those receiving paclitaxel-coated balloons, according to three-year results from the SIRONA clinical trial presented at TCT 2026. While both treatments showed…

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to economictimes.indiatimes.com's own reporting rather than reproducing it — the excerpt above comes from economictimes.indiatimes.com's own feed.